Genetic-Code-Expanded Cell-Based Therapy for Treating Diabetes in Mice

Scientists engineered a genetic code expansion-based therapeutic system, termed noncanonical amino acids (ncAAs)-triggered therapeutic switch, to achieve fast therapeutic protein expression in response to cognate ncAAs at the translational level.